Global /South Korea /Healthcare /Drug Manufacturers - General /001060

JW Pharmaceutical Corp.

001060

• KRX: 001060 • Delayed

31,200KRW -2.8%

20.35 USD

As of 5 June 2026, JW Pharmaceutical Corp. has a market cap of $478.01M USD, ranking #15438 globally and #458 in South Korea. It ranks #1377 in the Healthcare sector, and #510 in the Drug Manufacturers - General industry.

Global Rank

15438

Country Rank

458

Sector Rank

1377

Industry Rank

510

Key Stats

Market Cap

$478.01MUSD

732.7B KRW

Enterprise Value

$473.63MUSD

725.99B KRW

Revenue (TTM)

$505.8MUSD

775.3B KRW

EBITDA (TTM)

$69.56MUSD

106.62B KRW

Net Income (TTM)

$40.13MUSD

61.51B KRW

EBITDA Margin

14%

Profit Margin

7.9%

PE Ratio

12.7

PS Ratio

0.9

PB Ratio

2.0

EV/EBITDA

6.7

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

1,068

Founded

1945

Website

jw-pharma.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.8%	6.1%	0.2%	5.9%	37%	26%	48%	44%	19%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	001060 JW중외제약(주) ISIN: KR7001060003 Shares Out.: Shares Outstanding: 22.549M¹ Shares Float: 11.533M² TV: TradingView: KRX: 001060 SA: Stock Analysis: KRX: 001060 YF: Yahoo Finance: 001060.KS GF: Google Finance: KRX: 001060 BA: Barron's: 001060 MS: Morningstar: XKRX: 001060	31,200 KRW	TV: TradingView: KRX: 001060 SA: Stock Analysis: KRX: 001060 YF: Yahoo Finance: 001060.KS GF: Google Finance: KRX: 001060 BA: Barron's: 001060 MS: Morningstar: XKRX: 001060
Korea Exchange (KRX) MIC: XKRX	001065 JW중외제약(주) Pfd Shs Non-Voting ISIN: KR7001061001 TV: TradingView: KRX: 001065 SA: Stock Analysis: KRX: 001065 YF: Yahoo Finance: 001065.KS GF: Google Finance: KRX: 001065 BA: Barron's: 001065 MS: Morningstar: XKRX: 001065	27,350 KRW	TV: TradingView: KRX: 001065 SA: Stock Analysis: KRX: 001065 YF: Yahoo Finance: 001065.KS GF: Google Finance: KRX: 001065 BA: Barron's: 001065 MS: Morningstar: XKRX: 001065

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About JW Pharmaceutical Corp.

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is based in Gwacheon-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.07B 13.91T KRW 2K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.72B 10.3T KRW 1K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.2B 7.97T KRW 988%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.92B 7.55T KRW 930%	-	South Korea
Yuhan Corp. KRX: 000100	$4.51B 6.92T KRW 845%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.41B 6.76T KRW 822%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 159K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 114K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 75K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 68K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 60K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 58K%	20.5	Switzerland

chevron_leftBack